Cargando…

Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms

OBJECTIVE: The objective of this study was to validate claims‐based algorithms for identifying acute giant cell arteritis (GCA) that will help generate real‐world evidence on comparative effectiveness research and epidemiologic studies. Among patients identified by the GCA algorithm, we further inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hemin, Tedeschi, Sara K., Chen, Sarah K., Monach, Paul A., Kim, Erin, Liu, Jun, Pethoe‐Schramm, Attila, Yau, Vincent, Kim, Seoyoung C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882520/ https://www.ncbi.nlm.nih.gov/pubmed/33491920 http://dx.doi.org/10.1002/acr2.11218

Ejemplares similares

The Immunopathology of Giant Cell Arteritis Across Disease Spectra
por: Robinette, Michelle L., et al.
Publicado: (2021)

Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources
por: Monemi, Sharareh, et al.
Publicado: (2016)

Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)
por: Mahr, Alfred, et al.
Publicado: (2021)

Distinguishing laboratory characteristics in giant cell arteritis: a real-world retrospective cohort study
por: Goel, Raghav, et al.
Publicado: (2023)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Clinical Experience With a Multidisciplinary Model of Vascular Ultrasound for the Evaluation for Giant Cell Arteritis
por: Tedeschi, Sara K., et al.
Publicado: (2021)

Identification of Herpes Zoster–Associated Temporal Arteritis Among Cases of Giant Cell Arteritis
por: BUCKINGHAM, ERIN M., et al.
Publicado: (2017)

The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study
por: Dar, Lior, et al.
Publicado: (2021)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
por: Gale, Sara, et al.
Publicado: (2019)

Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK
por: Gale, Sara, et al.
Publicado: (2018)

Patients’ Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World Study
por: Dumain, Cyril, et al.
Publicado: (2022)

Misclassification of Obesity in Claims Data
por: Suissa, Karine, et al.
Publicado: (2021)

Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
por: Fox, Robert J., et al.
Publicado: (2022)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Giant Cell Arteritis and Cardiac Comorbidity
por: Arias, Magela, et al.
Publicado: (2021)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022)

Treatment of Giant Cell Arteritis (GCA)
por: Régent, Alexis, et al.
Publicado: (2022)

An Unusual Case of Giant Cell Arteritis
por: Goyal, Nitasha, et al.
Publicado: (2022)

Evolution of ultrasound in giant cell arteritis
por: Kirby, Colm, et al.
Publicado: (2022)

Cardiovascular lesions in giant cell arteritis
por: Dzhus, Marta, et al.
Publicado: (2022)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
por: Unizony, Sebastian, et al.
Publicado: (2021)

Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab
por: Hara, Kazusato, et al.
Publicado: (2021)

Clinical Images: Pulmonary Arteritis in Clinically Occult Aneurysmal Giant Cell Arteritis
por: Johnson, Victoria L, et al.
Publicado: (2021)

Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin?
por: Mortensen, Peter W., et al.
Publicado: (2022)

Giant Cell Arteritis Presenting as Small Bowel Infarction
por: Annamalai, Aniyizhai, et al.
Publicado: (2007)

Body Mass Index Variable Interpolation to Expand the Utility of Real-world Administrative Healthcare Claims Database Analyses
por: Wu, Bingcao, et al.
Publicado: (2021)

CO56 Real-World Effectiveness of Early Treatments for COVID-19: Evidence from Administrative Claims Data
por: Bell, C., et al.
Publicado: (2023)

Giant cell arteritis: A case report and review of literature
por: Crain, Matthew A., et al.
Publicado: (2021)

Real-world patterns of pegloticase use for treatment of gout: descriptive multidatabase cohort study
por: Chen, Sarah K, et al.
Publicado: (2020)

Giant Cell Arteritis Presenting as Choroidal Infarction
por: Kopsachilis, Nikolaos, et al.
Publicado: (2013)

Abdominal aortic aneurysm in giant cell arteritis
por: Kwon, Hyunwook, et al.
Publicado: (2015)

Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013)

Giant Cell Arteritis Presenting as Scalp Necrosis
por: Maidana, Daniel E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g5iunarjvrrcc0e1bqu9ilggja